We are pleased to announce that Nami Surgical has secured £3.4 million in a funding round extension led by a £2 million investment from the The Scottish National Investment Bank, with continued backing from our existing investors Eos Advisory, Scottish Enterprise and the Investment Fund for Scotland, managed by Maven Capital Partners and delivered by the British Business Bank.
As robotic-assisted surgery expands worldwide, so does the need for advanced energy instruments designed for robotic systems. Nami’s patented platform miniaturises the ultrasonic transducer, enabling a scalpel that articulates within wristed robotic instruments while delivering the full cutting and sealing capability of ultrasonic energy.
The round follows a year of strong progress and positions Nami for its next phase of growth. It will enable us to expand our commercial and engineering teams, accelerate development of our ultrasonic platform and strengthen our partnerships with leading companies across the global surgical robotics market.
We would like to thank our investors for their continued confidence in Nami, and our team, whose commitment and expertise have brought us to this point.
We look forward to the next chapter as we continue working to establish Nami as a technology partner of choice in robotic surgery.
Read the full press release here: https://lnkd.in/eAwuGM9W
#RoboticSurgery#UltrasonicEnergy#MedicalDevices#NamiSurgical



















